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AbstrACt
Objectives To determine the mediating effects of 
depression on health-related quality of life and fatigue in 
individuals with multiple sclerosis (MS).
Design A cross-sectional study.
setting Tertiary urban hospital.
Participants One hundred and eight patients (54% 
women) with MS participated in this study.
Outcome measures Demographic and clinical data 
(weight, height, medication and neurological impairment), 
fatigue (Fatigue Impact Scale), depression (Beck 
Depression Inventory-II) and health-related quality of life 
(Short-Form Health Survey 36) were collected.
results Fatigue was significantly associated with bodily 
pain, physical function, mental health and depression. 
Depression was associated with bodily pain and mental 
health. The path analysis found direct effects from physical 
function, bodily pain and depression to fatigue (all, 
P<0.01). The path model analysis revealed that depression 
exerted a mediator effect from bodily pain to fatigue 
(B=−0.04, P<0.01), and from mental health to fatigue 
(B=−0.16, P<0.01). The amount of fatigue explained by all 
predictors in the path model was 37%.
Conclusions This study found that depression mediates 
the relationship between some health-related quality of life 
domains and fatigue in people with MS. Future longitudinal 
studies focusing on proper management of depressive 
symptoms in individuals with MS will help determine the 
clinical implications of these findings.
IntrODuCtIOn 
Multiple sclerosis (MS) is a chronic demye-
linating disease of the central nervous system 
and includes a variety of symptoms that inter-
fere with daily activities, social and working 
life, disturb emotional well-being, and reduce 
quality of life. A worldwide annual incidence 
of 5.2 per 100 000 persons and a prevalence 
of 112 cases per 100 000 habitants have been 
reported.1 In Spain, the prevalence of MS has 
been found to be 125 cases per 100 000 habi-
tants2; however, recent studies have observed 
an increased prevalence in the previous 
decade.3 4 
Among all symptoms experienced by 
people with MS, fatigue is considered one 
of the most disabling.5 The prevalence of 
fatigue in MS ranges from 53% to 80%.6 
Fatigue is a risk indicator for conversion from 
moderate-severe disability to relapsing-re-
mitting MS.7 In fact, fatigue is influenced by 
several aspects such as psychological status, 
social relationship, personal beliefs, as well as 
personal interaction with the environment.8 
Among all potential relationships, depres-
sion and health-related quality of life exhibit 
the greatest impact on fatigue in people with 
MS.9 10
strengths and limitations of this study
 ► The main strength of this study was the inclusion of 
a homogeneous sample of individuals with multiple 
sclerosis and the use of specific statistical analyses.
 ► Since this was a cross-sectional study, the  cause 
and effect relationships between the associated 
variables cannot be inferred. In addition, the sample 
was composed of patients recruited from urban 
hospitals, not from the general population.
 ► The level of depression in our sample of individuals 
with multiple sclerosis was lower than expected. We 
do not know if the presence of higher symptoms 
of depression can lead to further associations or 
effects.
 ► We used a general but not disease-specific 
questionnaire to assess health-related quality of 
life. It is possible that the use of a disease-specific 
quality of life questionnaire would lead to other 
potential associations.
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Depression is the most prevalent comorbid condition 
reported by subjects with MS.11 12 It has been recently 
reported that the presence of depression is an important 
determinant of cognitive performance13 and quality 
of life14 in individuals with MS. In fact, the relation-
ship between related fatigue and depression is bidirec-
tional: fatigue can promote depression, but depression 
may also contribute to worsening self-perceived fatigue. 
However, the results from current literature are some-
times conflicting. Bakshi et al15 observed that fatigue was 
associated with depression, but independent of disability. 
Similarly, a recent study found that both fatigue and sleep 
disturbances contribute to the development of depres-
sion.16 Other authors have investigated the role of depres-
sion on fatigue. Kroencke et al17 found that depressed 
mood was a significant predictor of fatigue, accounting 
for approximately 23% of its variance. Nevertheless, 
others have reported that depression is not directly 
related to fatigue.18
Since depression and fatigue can be related by multiple 
interactions, additional studies including other variables 
such as health-related quality of life are needed. In fact, 
fatigue and depression can also influence self-perceived 
quality of life. Tanriverdi et al19 observed that fatigue and 
depression strongly influence the quality of life of individ-
uals with MS. Recent studies have reported that depres-
sion and fatigue, as well as related disability and physical 
comorbidities, are associated with health-related quality 
of life in people with MS.9 10 20 Future studies investigating 
the association between depression, health-related quality 
of life and fatigue in MS are necessary. In fact, a better 
understanding of the possible interaction between these 
multidimensional aspects associated with fatigue can 
potentially assist clinicians in determining better thera-
peutic programmes for individuals with MS. Therefore, 
the aim of the current study was to further determine 
the mediating effects of depression on the association 
between health-related quality of life and fatigue in indi-
viduals with MS. Since depression is the psychological 
disorder not intrinsically provoked by the disease, most 
commonly experienced by individuals with MS,11 12 we 
hypothesised that the relationships between health-re-
lated qualify of life and the MS-associated fatigue would 
be mediated by depressive symptoms.
MethODs
Patients diagnosed with definite MS according to 
the modified McDonald criteria21 by an experienced 
neurologist recruited from a local regional hospital in 
Madrid (Spain) between September 2013 and December 
2014 were screened for eligibility criteria. The exclu-
sion criteria included comorbid neurological diseases 
including herniated disc and other disorders of the 
spine, renal disease, cancer, diabetes mellitus, other 
psychiatric diseases and a Mini Mental State Examina-
tion score <25.22 Written informed consent was obtained 
from all participants prior to their inclusion in the study. 
All procedures were conducted according to the Decla-
ration of Helsinki.
Patients were recruited during their routine neuro-
logical visits and were screened and explored during a 
stationary phase of the disease. Patients completed a 
demographic and clinical questionnaire including age, 
sex, weight, height, medication and history of pain. 
Subjects underwent a neurological examination, and 
their neurological impairment was rated using the 
Expanded Disability Status Scale.23
Ms-related fatigue
MS-related fatigue was assessed using the Fatigue 
Impact Scale (FIS).24 The FIS is a 40-item questionnaire 
that includes three subscales assessing the impact of 
self-perceived fatigue on cognitive functioning (10 items), 
physical functioning (10 items) and psychosocial func-
tioning (20 items). Patients rate on a 5-point Likert scale 
if fatigue caused problems during the previous month (0: 
no problem; 4: extreme problem). The total score ranges 
from 0 to 84 points, where higher scores represent more 
fatigue. This questionnaire has exhibited good test–retest 
reliability and validity in people with MS.25 In this study, 
the validated Spanish version of the FIS was used as the 
main outcome.26
Depression
Depression was assessed using the Beck Depression Inven-
tory-II. It consists of 21 items that assess the affective, 
cognitive and somatic symptoms of depression.27 Patients 
choose from a group of sentences that best describe how 
they had been feeling in the preceding 2 weeks. The score 
ranges from 0 to 63 points, where higher score suggests 
higher level of depressive symptoms.28 This questionnaire 
has exhibited good internal consistency and good conver-
gent and divergent validity in individuals with MS.29
health-related quality of life
The Short-Form Health Survey 36 (SF-36) was used to 
assess health-related quality of life. This questionnaire 
assesses eight domains, namely physical function, physical 
role, bodily pain, general health, vitality, social function, 
role-emotional and mental health.30 Each domain is stan-
dardised on scores ranging from 0 to 100 points, where 
higher scores represent better quality of life. The SF-36 
has shown the ability to discriminate between subjects 
with health problems and asymptomatic individuals.31 32 
In the current study, the validated Spanish version of the 
SF-36 questionnaire was used.33
statistical analysis
Means, SD and CIs were calculated to describe the sample. 
The Kolmogorov-Smirnov test revealed that all quantita-
tive data exhibited a normal distribution. To determine 
the relationship between fatigue and the remaining vari-
ables, that is, depression and health-related quality of life 
domains, different Pearson product-moment correlation 
coefficients were first assessed.
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Second, a path model with maximum likelihood esti-
mation was applied to evaluate the effects of depression 
between the variables significantly associated with fatigue 
using the AMOS computer program.34 A path model is 
defined as a diagram relating independent (exposure), 
intermediary (mediating) and dependent (outcome) 
variables.35 In our hypothesised model, fatigue was the 
dependent variable, health-related quality of life domains 
were the independent variables, and depression the inter-
mediate, mediating variable of fatigue. In a path analysis, 
single arrows indicate causation between intermediary 
and dependent variable. Further, arrows also connect the 
error terms with their respective intermediary variables. 
Double arrows indicate correlation between pairs of inde-
pendent variables. The path coefficient is a standardised 
regression coefficient (beta) showing the direct effect of 
an independent variable (health-related quality of life 
domain) on the dependent (fatigue) variable. Indirect 
effects occur when the relationship between two variables 
(eg, fatigue and mental health) is mediated by one or 
more variables (ie, depression).
Previous conditions from data were assessed: linearity, 
additivity, interval-level data, recursivity, low multicol-
linearity and adequate sample size.36 Confirmation of 
the adequacy of the model was conducted within abso-
lute fit indices.37 38 AMOS provides several fit indices that 
are largely independent of the sample size: the Good-
ness of Fit Index (GFI) and Adjusted Goodness of Fit 
Index (AGFI), whose value reference is at 90 to consider 
an acceptable model39; and the Comparative Fit Index 
(CFI), Normed Fit Index (NFI) and Tucker-Lewis Index 
(TLI), which are also adequate if their values are over 
0.90.38 Finally, within parsimony adjustment indices, the 
error of the root mean square approximation (RMSEA) 
whose values <0.08 or less is good.40 There was no missing 
data since the sample was composed by the final subjects 
satisfying all inclusion criteria (n=108).
results
One hundred and twenty (n=120) consecutive subjects 
with MS were screened for eligibility criteria. One hundred 
and eight (n=108, 90%) (54% women; mean age 44±8 
years; height 170±9 cm; weight 71±15 kg) satisfied all 
the eligibility criteria, agreed to participate and signed 
the informed consent. The reasons for exclusion were 
as follows: previous surgery (n=6), pregnancy (n=2) and 
older than 65 years old (n=4). The demographic and clin-
ical data of the total sample are listed in table 1.
Correlation analysis
Table 2 shows the Pearson’s correlation coefficients 
between variables included in the path model showing 
significant association with fatigue. Fatigue was signifi-
cantly negatively associated (higher score) with bodily 
pain (r=−0.48, P<0.01), physical function (r=−0.31, 
P<0.01) and mental health (r=−0.42, P<0.01), and also 
significantly positively associated with depression (r=0.47, 
P<0.01): the higher the self-perceived fatigue, the worse 
physical function, the worse mental health, the higher 
bodily pain or the higher depressive symptom. Depression 
was also negatively associated with bodily pain (r=−0.40, 
P<0.01) and mental health (r=−0.61, P<0.01): the worse 
mental health or higher presence of bodily pain, the 
higher the level of depression.
Path analysis
The hypothesised model fit of the data was excellent 
with GFI of 0.98, AGFI of 0.91, CFI of 0.98, TLI of 0.94 
and NFI of 0.97. Further, the RMSEA was 0.08. Figure 1 
displays the parameter estimates (standardised solution).
According to the direct effects, a significant path was 
noted from mental health (B=−0.53, P<0.01) to depres-
sion, with an SE of 0.035. Likewise, significant paths were 
also indicated between physical function (B=−0.23, P<0.01, 
SE=0.054), bodily pain (B=−0.36, P<0.01, SE=0.070) and 
depression (B=0.29, P<0.01, SE=0.025) on fatigue. The 
direct effect from bodily pain on depression did not reach 
significance (B=−0.15, P=0.07, SE=0.024). Furthermore, 
significant indirect effects in the path analysis model from 
bodily pain to fatigue mediated by depression (B=−0.04, 
P<0.01, SE=0.031), and from mental health to fatigue also 
mediated by depression (B=−0.16, P<0.01, SE=0.015), 
Table 1 Demographics and specific disease clinical data 
for the total sample (n=108)*
Gender (male/female), n (%) 49 (45)/59 (55)
Age (years) 44±8 (42 to 45)
Height (cm) 170±9 (168 to 172)
Weight (kg) 71.5±15 (68 to 75)
Disease course, n (%) 
  Relapsing-remitting 80 (74) 
  Secondary progressive 19 (18)
  Primary progressive 8 (8) 
Disease duration (years) 12.5±8.0 (11.0 to 14.2)
EDDS (0–10) 3.4±1.7 (3.1 to 3.8)
FIS (total score, 0–84) 38.7±19.2 (34.9 to 42.5)
Physical function (SF-36, 0–100) 55.5±27.8 (49.9 to 60.9)
Physical role (SF-36, 0–100) 49.5±40.7 (41.4 to 57.6)
Bodily pain (SF-36, 0–100) 66.2±23.5 (62.5 to 70.8)
General health (SF-36, 0–100) 44.8±21.1 (40.6 to 49.1)
Vitality (SF-36, 0–100) 44.9±19.8 (40.9 to 48.8)
Social function (SF-36, 0–100) 71.2±24.2 (66.4 to 76.0)
Emotional role (SF-36, 0–100) 78.3±35.9 (71.2 to 85.4)
Mental health (SF-36, 0–100) 68.6±16.4 (65.4 to 71.9)
BDI-II (0–63) 10.2±6.7 (8.8 to 11.5)
*Data are mean±SD (95% CI).
BDI-II, Beck Depression Inventory-II; EDSS, Expanded Disability 
Status Scale; FIS, Fatigue Impact Scale; SF-36, Short-Form Health 
Survey 36.
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were observed. Overall, the amount of fatigue explained 
by all predictors in the model was R2=0.37.
DIsCussIOn
The present study demonstrated that depression medi-
ates the relationship between some health-related quality 
of life domains, such as mental health and bodily pain, 
and fatigue in individuals with MS. These results support 
the assumption that depression is related to fatigue and 
that it can mediate the effects of health-related quality of 
life in individuals with MS.
Our findings have shown, first and in accordance 
with prior literature,9 10 14–17 that depression is a psycho-
logical factor directly associated with fatigue in people 
with MS. However, previous studies have not investi-
gated the mediating effects of depression on the asso-
ciation with other variables. The current study showed 
that depression mediated the association between some 
health-related quality of life domains, such as bodily pain 
and mental health, and fatigue, suggesting that depres-
sive levels mediate the contribution of quality of life to 
related fatigue. The relevance of depression was further 
supported by the fact that depression also showed an 
effect on self-perceived fatigue in our sample of subjects 
with MS. This means that depression has an influence 
on fatigue, but also other mediating influences in other 
outcomes. This finding is quite interesting if we consider 
that the depression symptoms of our sample of people 
with MS were low since scores reflected minimal or mild 
signs of depression.27 It is plausible that higher levels of 
depression may reveal stronger relationships.
The association between mental health and fatigue in 
MS is not new since some studies have reported that fatigue 
contributes to mental fatigue, worse emotional well-being 
Table 2 Pearson product-moment correlation matrix for the study variables included in the path model
Mean SD 95% CI Kurtosis Skewness 1 2 3 4
Fatigue (Fatigue Impact 
Scale, 0–84)
38.7 19.2 34.9 to 42.5 −0.48 0.22
Bodily pain (0–100) 66.2 23.5 62.5 to 70.8 −0.46 −0.28 −0.488**
Physical function (0–100) 55.5 27.8 49.9 to 60.9 −1.20 0.00 −0.308** 0.072
Mental health (0–100) 68.6 16.4 65.4 to 71.9 −0.70 −0.15 −0.424** 0.468** 0.106
Depression (0–63) 10.2 6.7 8.8 to 11.5 0.33 0.72 0.475** −0.403** −0.184 −0.606**
Skewness SE=0.23; kurtosis SE=0.46.
**P < 0.01. 
Figure 1 Path analyses relating mental health, bodily pain and physical function with fatigue with the intermediate effect of 
depression. Standardised direct path coefficients are presented. In this model mental health predicts depression, while the 
independent variable (fatigue) is predicted by depression and also directly by physical activity. The straight arrows represent 
regression paths for presumed causal relationships, while the curved double-headed arrows represent assumed correlations 
among the variables.
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and worse cognitive performance.41 42 The novelty of 
the current study was that the effect of mental health on 
fatigue was mediated by depression. This is an expected 
finding, since depression contributes to worse cognitive 
performance.13 It would be reasonable to consider that 
individuals with MS suffering from fatigue experience 
worse cognitive function, which may in turn provoke 
depressive symptoms, and therefore increase the self-per-
ceived fatigue. Bidirectional reinforcement between 
mental health and depression can create a vicious cycle 
by promoting self-perceived fatigue in people with MS.
Another health-related quality of life domain that was 
directly associated with fatigue was bodily pain. This was 
expected since the presence of pain also contributes 
to fatigue.43 Nevertheless, similar to mental health, the 
effect of bodily pain on fatigue was mediated by depres-
sion. It can be hypothesised that pain induces depression 
and that pain will promote a worse fatigue self-percep-
tion. This hypothesis is also supported by another study 
that used a similar analysis with our study, where higher 
pain levels were associated with fatigue, which in turn 
were associated with higher depression.44 Current and 
previous findings suggest that proper management of 
depressive symptoms would be a key element in the treat-
ment of pain in individuals with MS, although further 
studies are needed.
The path model also identified that physical function 
was associated with self-perceived fatigue in our sample of 
individuals with MS. In this case, the association of phys-
ical function and fatigue was not mediated by depression, 
supporting a direct effect between these variables. These 
findings are similar to the results by Turpin et al,45 who 
found that patients with MS with greater fatigue and 
disability exhibited poorer physical activity. Again, it is 
expected that individuals reporting greater fatigue have 
lower physical activity. It is possible that this association 
could influence other psychological outcomes included 
in our path analysis, since fatigue may contribute to 
depression by reducing physical function as a result of 
lack of energy.46 These associations support a complex 
interaction among physical outcomes, depressive symp-
toms and fatigue.
With uncertainty over biological mechanisms 
accounting for these interactions, the current results 
have important clinical implications. Our results indicate 
that depression, that is, an emotional status not directly 
caused by the condition, plays a relevant role in the rela-
tionship between fatigue and health-related quality of 
life in people with MS. Therefore, our results suggest 
that proper management of depression can be effective 
in improving self-perceived fatigue in people with MS by 
impacting mental health and bodily pain. It is possible 
that management of fatigue by treating depressive symp-
toms would lead to an increase in physical activity in 
these individuals. This hypothesis is supported by a recent 
review reporting that proper psychological management 
produced improvements in both psychological and physi-
ological outcomes in patients with MS.47 However, future 
randomised clinical trials are needed to confirm this 
hypothesis.
There are a number of limitations that should be 
recognised. First, we used a cross-sectional design; there-
fore, the cause and effect relationships between the 
variables cannot be inferred. Second, the sample was 
composed of patients with MS recruited from different 
urban hospitals. Therefore, extrapolation of the current 
results to more diverse populations should be conducted 
with caution. Additionally, we used a non-probabilistic 
sampling for a finite population to calculate our sample 
size. This was conducted applying a 95% confidence level 
and a sampling error for the final set of participants under 
5%. Although we could not estimate a priori sample size, 
we believe that our sample is representative of the popu-
lation. Third, the level of depressive symptoms in our 
sample of patients with MS was lower than expected. In 
fact, scores showed that almost all participants exhibited 
small depressive levels. It is possible that the presence 
of higher symptoms of depression can lead to further 
associations or effects. Fourth, we should consider that 
health-related quality of life was assessed with a general, 
but not disease-specific, questionnaire. It is possible that 
the use of an MS-specific quality of life questionnaire, that 
is, Multiple Sclerosis Quality of Life (MSQoL-54), would 
lead to other potential associations. Finally, other poten-
tial confounder variables, such as sleep disturbances or 
anxiety, that could give a broader vision of the biopsy-
chosocial model approach were not included. This study 
would benefit from longitudinal data to further deter-
mine the impact of proper management of depressive 
symptoms on the identified associations over time in 
patients with MS.
COnClusIOns
This study found that depression mediated the relation-
ship between mental health and bodily pain, but not the 
association of physical activity, and fatigue in people with 
MS. These results support the assumption that depression 
is directly related with fatigue and that it can mediate the 
effects of health-related quality of life in individuals with 
MS. Future longitudinal studies will help determine the 
clinical implications of these findings.
Contributors All authors contributed to the study concept and design. JJF-M 
and CFdlP did the main statistical analysis and interpretation of data. CFdlP, 
MC-M and PP-B contributed to drafting the report. MCM, EN-P and PP-B provided 
administrative, technical and material support. EN-P and MPdH-T supervised 
the study. All authors revised the text for intellectual content and have read and 
approved the final version of the manuscript.
Funding This research received no specific grant from any funding agency in the 
public, commercial or not-for-profit sectors. 
Competing interests None declared.
Patient consent Obtained.
ethics approval This study was approved by the local ethical research 
committee of the Hospital Universitario Fundación Alcorcón (HUFA 11/087), 
Madrid, Spain.
Provenance and peer review Not commissioned; externally peer reviewed.
group.bmj.com on April 15, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
6 Fernández-Muñoz JJ, et al. BMJ Open 2018;8:e016297. doi:10.1136/bmjopen-2017-016297
Open Access 
Data sharing statement Extra data can be accessed via the Dryad data repository 
at http:// datadryad. org/ with the doi: 10.5061/dryad.vp955.
Open Access This is an Open Access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited and the use is non-commercial. See: http:// creativecommons. org/ 
licenses/ by- nc/ 4. 0/
© Article author(s) (or their employer(s) unless otherwise stated in the text of the 
article) 2018. All rights reserved. No commercial use is permitted unless otherwise 
expressly granted.
reFerenCes
 1. Melcon MO, Correale J, Melcon CM. Is it time for a new global 
classification of multiple sclerosis? J Neurol Sci 2014;344:171–81.
 2. Fernández O, Fernández V, Guerrero M, et al. Multiple sclerosis 
prevalence in Malaga, Southern Spain estimated by the capture-
recapture method. Mult Scler 2012;18:372–6.
 3. Otero-Romero S, Roura P, Solà J, et al. Increase in the prevalence of 
multiple sclerosis over a 17-year period in Osona, Catalonia, Spain. 
Mult Scler 2013;19:245–8.
 4. Candeliere-Merlicco A, Valero-Delgado F, Martínez-Vidal S, et al. 
Prevalence of multiple sclerosis in health district III, Murcia, Spain. 
Mult Scler Relat Disord 2016;9:31–5.
 5. Shah A. Fatigue in multiple sclerosis. Phys Med Rehabil Clin N Am 
2009;20:363–72.
 6. Braley TJ, Chervin RD. Fatigue in multiple sclerosis: mechanisms, 
evaluation, and treatment. Sleep 2010;33:1061–7.
 7. Cavallari M, Palotai M, Glanz BI, et al. Fatigue predicts disease 
worsening in relapsing-remitting multiple sclerosis patients. Mult 
Scler 2016;22:1841–9.
 8. Hadjimichael O, Vollmer T, Oleen-Burkey M. North American 
Research Committee on Multiple Sclerosis. Fatigue characteristics 
in multiple sclerosis: the North American Research Committee on 
Multiple Sclerosis (NARCOMS) survey. Health Qual Life Outcomes 
2008;6:100.
 9. Nourbakhsh B, Julian L, Waubant E. Fatigue and depression predict 
quality of life in patients with early multiple sclerosis: a longitudinal 
study. Eur J Neurol 2016;23:1482–6.
 10. Kargarfard M, Eetemadifar M, Mehrabi M, et al. Fatigue, depression, 
and health-related quality of life in patients with multiple sclerosis in 
Isfahan, Iran. Eur J Neurol 2012;19:431–7.
 11. Marrie RA, Patten SB, Tremlett H, et al. Sex differences in 
comorbidity at diagnosis of multiple sclerosis: a population-based 
study. Neurology 2016. [Epub ahead of print 9 Mar 2016].
 12. Marrie RA, Reingold S, Cohen J, et al. The incidence and prevalence 
of psychiatric disorders in multiple sclerosis: a systematic review. 
Mult Scler 2015;21:305–17.
 13. Nunnari D, De Cola MC, D'Aleo G, et al. Impact of depression, 
fatigue, and global measure of cortical volume on cognitive 
impairment in multiple sclerosis. Biomed Res Int 2015;2015:1–7.
 14. Fricska-Nagy Z, Füvesi J, Rózsa C, et al. The effects of fatigue, 
depression and the level of disability on the health-related quality 
of life of glatiramer acetate-treated relapsing-remitting patients with 
multiple sclerosis in Hungary. Mult Scler Relat Disord 2016;7:26–32.
 15. Bakshi R, Shaikh ZA, Miletich RS, et al. Fatigue in multiple sclerosis 
and its relationship to depression and neurologic disability. Mult Scler 
2000;6:181–5.
 16. Edwards KA, Molton IR, Smith AE, et al. Relative importance of 
baseline pain, fatigue, sleep, and physical activity: Predicting change 
in depression in adults with multiple sclerosis. Arch Phys Med 
Rehabil 2016;97:1309–15.
 17. Kroencke DC, Lynch SG, Denney DR. Fatigue in multiple sclerosis: 
relationship to depression, disability, and disease pattern. Mult Scler 
2000;6:131–6.
 18. Šabanagić-Hajrić S, Suljić E, Kučukalić A. Fatigue during multiple 
sclerosis relapse and its relationship to depression and neurological 
disability. Psychiatr Danub 2015;27:406–12.
 19. Tanriverdi D, Okanli A, Sezgin S, et al. Quality of life in patients with 
multiple sclerosis in Turkey: relationship to depression and fatigue.  
J Neurosci Nurs 2010;42:267–73.
 20. Berrigan LI, Fisk JD, Patten SB, et al. Health-related quality of life 
in multiple sclerosis: direct and indirect effects of comorbidity. 
Neurology 2016.
 21. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for 
multiple sclerosis: 2010 revisions to the McDonald criteria. Ann 
Neurol 2011;69:292–302.
 22. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". a 
practical method for grading the cognitive state of patients for the 
clinician. J Psychiatr Res 1975;12:189–98.
 23. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: 
an expanded disability status scale (EDSS). Neurology 
1983;33:1444–52.
 24. Fisk JD, Ritvo PG, Ross L, et al. Measuring the functional impact of 
fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 
1994;18(Suppl 1):S79–83.
 25. Mathiowetz V. Test-retest reliability and convergent validity of the 
fatigue impact scale for persons with multiple sclerosis. Am J Occup 
Ther 2003;57:389–95.
 26. Benito-León J, Martínez-Martín P, Frades B, et al. Impact of fatigue 
in multiple sclerosis: the Fatigue Impact Scale for daily use (D-FIS). 
Mult Scler 2007;13:645–51.
 27. Beck AT, Steer RA, Brown GK, et al. Beck depression inventory. 2nd 
ed. San Antonio, Texas: The Psychological Corporation, 1996.
 28. Beck AT, Steer RA, Carbin MG. Psychometric properties of the beck 
depression inventory: twenty-five years of evaluation. Clin Psychol 
Rev 1988;8:77–100.
 29. Sacco R, Santangelo G, Stamenova S, et al. Psychometric properties 
and validity of beck depression inventory ii in multiple sclerosis. Eur J 
Neurol 2016;23:744–50.
 30. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey 
(SF-36). I. Conceptual framework and item selection. Med Care 
1992;30:473–83.
 31. Ware JE, Snow KK, Kosinski M, et al. SF-36 Health Survey: manual 
and interpretation guide. Boston, MA: New England Medical Center, 
The Health Institute, 1993.
 32. The Canadian Burden of Illness Study Group. Burden of illness 
of multiple sclerosis: part II: quality of life. Can J Neurol Sci 
1998;25:31–8.
 33. Alonso J, Prieto L, Antó JM. [The spanish version of the SF-36 health 
survey (the sf-36 health questionnaire): an instrument for measuring 
clinical results]. Med Clin 1995;104:771–6.
 34. Abuckle JL, Wothke W. Amos 4.0 users guide. Chicago: Small 
waters, 1999.
 35. Duncan OD. Path analysis: sociological examples. Am J Sociol 
1966;72:1–16.
 36. Kline RB. Principles and practice of structural equation modeling. 
2nd ed. New York: Guilford, 2005.
 37. Jöreskog KG, Sörbom D. Advanced in factor analysis and structural 
equation models. Cambridge: M.A. Abl, 1979.
 38. Bentler PM. Comparative fit indexes in structural models. Psychol 
Bull 1990;107:238–46.
 39. Hu Li‐tze, Bentler PM. Cut-off criteria for fit indexes in covariance 
structure analysis: conventional criteria versus new alternatives. 
Structural Equation Mod 1999;6:1–55.
 40. Steiger JH, Lind C. Statistically based tests for the number of 
common factors. Iowa City, IA: Paper presented at the annual 
meeting of the Psychometric Society, 1980.
 41. Lerdal A, Celius EG, Krupp L, et al. A prospective study of patterns of 
fatigue in multiple sclerosis. Eur J Neurol 2007;14:1338–43.
 42. Ukueberuwa DM, Arnett PA. Evaluating the role of coping style as 
a moderator of fatigue and risk for future cognitive impairment in 
multiple sclerosis. J Int Neuropsychol Soc 2014;20:751–5.
 43. Shahrbanian S, Duquette P, Ahmed S, et al. Pain acts through fatigue 
to affect participation in individuals with multiple sclerosis. Qual Life 
Res 2016;25:477–91.
 44. Amtmann D, Askew RL, Kim J, et al. Pain affects depression through 
anxiety, fatigue, and sleep in multiple sclerosis. Rehabil Psychol 
2015;60:81–90.
 45. Turpin KV, Carroll LJ, Cassidy JD, et al. Deterioration in the health-
related quality of life of persons with multiple sclerosis: the possible 
warning signs. Mult Scler 2007;13:1038–45.
 46. Penner IK, Bechtel N, Raselli C, et al. Fatigue in multiple sclerosis: 
relation to depression, physical impairment, personality and action 
control. Mult Scler 2007;13:1161–7.
 47. Pagnini F, Bosma CM, Phillips D, et al. Symptom changes in multiple 
sclerosis following psychological interventions: a systematic review. 
BMC Neurol 2014;14:222.
group.bmj.com on April 15, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
sclerosis? A Spanish cross-sectional study
depression in patients with multiple
quality of life and fatigue mediated by 
Is the association between health-related
César Fernández-de-las-Peñas
Navarro-Pardo, Marta Pérez-de-Heredia-Torres, Paula Parás-Bravo and 
Juan J Fernández-Muñoz, Margarita Cigarán-Méndez, Esperanza
doi: 10.1136/bmjopen-2017-016297
2018 8: BMJ Open
 http://bmjopen.bmj.com/content/8/1/e016297




This article cites 39 articles, 0 of which you can access for free at: 
Open Access
 http://creativecommons.org/licenses/by-nc/4.0/non-commercial. See: 
provided the original work is properly cited and the use is
non-commercially, and license their derivative works on different terms, 
permits others to distribute, remix, adapt, build upon this work
Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
This is an Open Access article distributed in accordance with the Creative
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections




To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on April 15, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
